Senolytic drugs: from discovery to translation Kirkland JL, Tchkonia T Journal of Internal Medicine (2020) This comprehensive review from the Mayo Clinic's leading senescence researchers places FOXO4-DRI within the broader context of senolytic drug development and clinical translation
3.2 Resolution pharmacology to target fibroblasts mediated diseases everal mediators and their derivatives, acting on various pro-resolving receptors have been tested in fibroblasts and in animal models of fibrosis
If you take hormone-related medications, check interactions before starting any peptide
The final matched analysis included seven obesity-related cancers: breast, prostate, non-small cell lung, colorectal, liver, kidney, and pancreatic cancers
[DOI] [PubMed] [Google Scholar] 14.Olsson B., Johansson M., Gabrielsson J., Bolme P
Theres a medical reason to have that conversation. Reviewed by Suki K